Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
Discover stocks with +10X upside potential.
Our recent winners include: CYDY +2,000%, IPNFF +1,700%, NEXCF +1,300%
Join now, and discover the next big winner!